Britain tries to cool AstraZeneca concerns as its CEO touts a new vaccine trial
...
The U.K. governments top scientific advisor, Patrick Vallance, said the focus should be on the fact that the vaccine actually works when asked about doubts regarding the trial.
The headline result is the vaccine works and thats very exciting, Vallance said during a news conference on Thursday. Chief Medical Advisor Chris Whitty echoed his comments at the same conference, saying there was always scientific debate about virtually everything.
The key thing from our point of view is to leave this in the hands of the regulator ... They will make an assessment with lots of data that is not currently in the public domain on efficacy and on safety, Whitty added.
Rollout next month
Britain has asked its medicine regulator to assess the vaccine for a temporary supply, which could mean its rolled out in the country before the end of the year. Four million doses could be used in Britain next month but concerns in the U.S. could mean a rollout there could come much later.
The 70% figure came from combining a smaller group of people who received an unintentionally lower dose of the vaccine which produced 90% efficacy, and a larger group who received a higher dosage, showing only 62% effectiveness.
https://www.cnbc.com/2020/11/27/britain-tries-to-cool-astrazeneca-concerns-ceo-touts-new-vaccine-trial.html